On Tuesday, Shares of DaVita HealthCare Partners Inc (NYSE:DVA), gained 0.38% to $74.36.
DaVita HealthCare Partners, declared that it has reached a contract to acquire Colorado-based Renal Ventures Limited, LLC – counting a 100 percent interest in all dialysis centers owned by Renal Ventures – for $415 million.
Javier Rodriguez, CEO of DaVita Kidney Care said, “We are excited to work with Renal Ventures’ patients, employees, and physicians. Our commitment is, and will always be about enhancing the quality of life for our patients. We look forward to serving Renal Ventures’ patients, with industry-leading outcomes and comprehensive care.”
Renal Ventures operates 36 dialysis clinics in six states. Multispecialty Physician Partners and Physician Venture Partners, divisions of Renal Ventures, operate infusion and vascular centers, respectively, in three states.
“Renal Ventures takes great pride in its culture of actively engaging our employees, patients and the communities we serve. The quality of care delivered by our caregivers, together with recognition as ‘Best Place to Work,’ are a source of pride,” said Larry Chatfield, CEO of Renal Ventures. “In recently’s changing health care environment, combining with DaVita, a patient-centric organization, will benefit all of our stakeholders.”
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners.
Shares of Workday Inc (NYSE:WDAY), inclined 1.00% to $70.03, during its last trading session.
The trading days couldn’t end soon enough for Workday Inc.’s shareholders today, according to WSJ.
Although the software provider isn’t particularly exposed to China, commodities, interest rates or any of the other scary themes that have been behind the market tumult, its shares fell by 18% in the week ended Monday. Those investors, who have been with the cloud-computing company for some time, while probably not enthused, have been through worse. In the spring of 2014, Workday and its peers went through what analysts at Evercore ISI dub “the SaaS Crash.”
Software as a service, or SaaS, company valuations bounced back from a steep drop then, but they never completely recovered. Workday, for example, went from trading at 27 times debt-adjusted market value to forward revenue to just half that multiple in under three months. Its recovery sputtered and it now fetches less than nine times. WSJ Reports
That makes Workday a bargain relative to its formerly loftier valuation. But it is far from an outright bargain, barring some fantastic news when the company reports fiscal second-quarter results on Wednesday. WSJ added.
Workday, Inc. provides enterprise cloud applications for finance and human resources in the United States and internationally. It offers applications for customers to manage critical business functions that enable them to optimize their financial and human capital resources.
At the end of Tuesday’s trade, Shares of Fortinet Inc (NASDAQ:FTNT), lost -0.68% to $40.64.
Fortinet, declared the launch of its FortiGate-600D enterprise firewall, the industry’s most competitive 10GBps mid-range network security appliance accessible to protect mid-market and enterprise organizations from advanced cyber attacks.
The new FortiGate-600D delivers five-time better performance contrast to competitive solutions, and provides the best price/performance in the industry. The solution is designed to provide superior security and performance for two key use cases:
- Deployment as a Next Generation Firewall (NGFW) at the edge of the network, allowing multiple security applications to be deployed without causing a bottleneck in the network.
- Deployment as an Internal Segmentation Firewall (ISFW), enabling customers to securely separate data stores inside the internal network — where traffic can run 10 to 100 times faster than Internet traffic — without affecting throughput.
Fortinet, Inc. provides cyber security solutions for enterprises, service providers, and government organizations worldwide. The company offers FortiGate physical and virtual appliances products that provide various integrated security and networking functions to protect data, applications, and users from network- and content-level security threats; FortiManager product family to manage the system configuration and security functions of multiple FortiGate devices from a centralized console; and the FortiAnalyzer product family, which enables the collection, analysis, and archiving of content and log data generated by its products.
Finally, CNO Financial Group Inc (NYSE:CNO), ended its last trade with -1.46% loss, and closed at $16.18.
CNO Financial Group, declared second quarter of 2015 operating earnings of $60.8 million, or 31 cents per diluted share, contrast to $71.3 million, or 32 cents per diluted share, in the second quarter of 2014.
Second Quarter 2015 Highlights
- Sales, as defined by total new annualized premium (“NAP”) (2): $105.5 million, up 1% from 2Q14
- Collected premium from our ongoing operating segments (3): $830.9 million down slightly from 2Q14
- Net income per diluted share: 24 cents in 2Q15 (counting 11 cents from the loss on extinguishment of debt) contrast to 35 cents in 2Q14
- Net operating income (1) per diluted share: 31 cents in 2Q15 contrast to 32 cents in 2Q14
- Unrestricted cash and investments held by our holding company were $385 million at June 30, 2015
- Common stock repurchases and dividends were $115 million in 2Q15
CNO Financial Group, Inc., through its auxiliaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. Its Bankers Life segment markets and distributes Medicare supplement insurance, interest sensitive and traditional life insurance, fixed annuities, and long term care insurance products; Medicare advantage plans primarily through distribution arrangements with Humana, Inc. and United HealthCare; and Medicare Part D prescription drug plans through a distribution and reinsurance arrangement with Coventry Health Care.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
